drugset / Trial / NCT00332553
Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
RandomizedParallel-groupDouble-blindPrevention
Summary
This pilot study was designed to explore the effects of combined treatment with raloxifene HCl 60 mg and oral 17 beta-estradiol 1mg/day on the number of vasomotor episodes (hot flashes plus night sweats) in postmenopausal women discontinuing continuous combined hormone replacement therapy (ccHRT) compared to women treated with raloxifene HCl 60 mg alone.
Timeline
- Start
- 2002-02
- Primary completion
- —
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 17-beta estradiol | Unknown | 1 mg | Oral |
| Subject | Raloxifene | Other / unclassified | 60 mg | — |
| Background | medroxyprogesterone acetate | Other / unclassified | — | — |
Indications
No indication recorded.